Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/201145
Title: | Population Pharmacokinetic Analysis of Perampanel in Portuguese Patients Diagnosed with Refractory Epilepsy |
Author: | Silva, Rui Colom Codina, Helena Bicker, Joana Almeida, Anabela Silva, Ana Sales, Francisco Santana, Isabel Falcão, Amílcar Fortuna, Ana |
Keywords: | Epilèpsia Farmacologia Portugal Epilepsy Pharmacology Portugal |
Issue Date: | 10-Jun-2023 |
Publisher: | MDPI AG |
Abstract: | Perampanel is a promising antiepileptic drug (AED) for refractory epilepsy treatment due to its innovative mechanism of action. This study aimed to develop a population pharmacokinetic (PopPK) model to be further used in initial dose optimization of perampanel in patients diagnosed with refractory epilepsy. A total of seventy-two plasma concentrations of perampanel obtained from forty-four patients were analyzed through a population pharmacokinetic approach by means of nonlinear mixed effects modeling (NONMEM). A one-compartment model with first-order elimination best described the pharmacokinetic profiles of perampanel. Interpatient variability (IPV) was entered on clearance (CL), while the residual error (RE) was modeled as proportional. The presence of enzyme-inducing AEDs (EIAEDs) and body mass index (BMI) were found as significant covariates for CL and volume of distribution (V), respectively. The mean (relative standard error) estimates for CL and V of the final model were 0.419 L/h (5.56%) and 29.50 (6.41%), respectively. IPV was 30.84% and the proportional RE was 6.44%. Internal validation demonstrated an acceptable predictive performance of the final model. A reliable population pharmacokinetic model was successfully developed, and it is the first enrolling real-life adults diagnosed with refractory epilepsy. |
Note: | Reproducció del document publicat a: https://doi.org/10.3390/pharmaceutics15061704 |
It is part of: | Pharmaceutics, 2023, vol. 15, num. 6 |
URI: | http://hdl.handle.net/2445/201145 |
Related resource: | https://doi.org/10.3390/pharmaceutics15061704 |
ISSN: | 1999-4923 |
Appears in Collections: | Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL)) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
pharmaceutics-15-01704-v2.pdf | 6.11 MB | Adobe PDF | View/Open |
This item is licensed under a
Creative Commons License